These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8635396)

  • 21. [Role of chemo(radio)theray prior to surgery for stage IIIa non-small cell lung carcinoma (localized non-resectable tumor)].
    Smit EF; van Mourik JC; Slotman BJ; Postmus PE
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):1992-6. PubMed ID: 10535055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neoadjuvant chemotherapy and chemoradiotherapy in surgically treated non-small-cell stage III bronchial carcinoma].
    Hillejan L; Müller MR; Eberhardt W; Stüben G; Stamatis G
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():601-5. PubMed ID: 11824324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant strategies for non-small cell lung cancer.
    van Zandwijk N
    Lung Cancer; 2001 Dec; 34 Suppl 2():S145-50. PubMed ID: 11720756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
    Roth JA; Fossella F; Komaki R; Ryan MB; Putnam JB; Lee JS; Dhingra H; De Caro L; Chasen M; McGavran M
    J Natl Cancer Inst; 1994 May; 86(9):673-80. PubMed ID: 8158698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of surgery in N2 non-small cell lung cancer.
    DeCamp MM; Ashiku S; Thurer R
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of neoadjuvant therapy in the treatment of locally advanced, stage III non-small-cell lung cancer].
    Balikó Z; Sárosi V
    Magy Onkol; 2005; 49(2):161-8. PubMed ID: 16249813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer.
    Movsas B
    Oncology (Williston Park); 2001 Dec; 15(12):1549-58. PubMed ID: 11780699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 36. Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?
    Mirimanoff RO
    Chin Clin Oncol; 2015 Dec; 4(4):49. PubMed ID: 26730761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
    Pujol JL; Hayot M; Rouanet P; Le Chevalier T; Michel FB
    Chest; 1994 Nov; 106(5):1451-5. PubMed ID: 7956400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer.
    Neville A
    Clin Evid; 2002 Jun; (7):1369-83. PubMed ID: 12230752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.